CIK 0001676725 · Large accelerated filer
IDEAYA Biosciences, Inc.
Sign in to watch- Ticker
- IDYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474268251
- Phone
- 650-443-6209
- Business address
- 5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $985,397
- in 1 filing, $985K under 10b5-1 plans
Net −$985,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 67 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-07 | Dillon Michael P. SVP, Chief Scientific Officer | Option exercise | +116 | $4.31 | $500 | 78,905 |
| 2021-09-07 | Dillon Michael P. SVP, Chief Scientific Officer | Sale | −116 | $27.46 | $3K | 78,789 |
| 2021-09-07 | Dillon Michael P. SVP, Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −116 | 66,119 | ||
| 2021-09-07 | Stone Paul A. SVP, Chief Financial Officer | Sale | −2,500 | $27.42 | $69K | 12,944 |
| 2021-09-02 | Dillon Michael P. SVP, Chief Scientific Officer | Sale | −10,000 | $25.09 | $251K | 78,789 |
| 2021-05-28 | Stone Paul A. SVP, Chief Financial Officer | Grant or award | +859 | $11.36 | $10K | 13,803 |
Page 10 of 10 · 186 trades